Molina Esquivel J, Vargas Sandoval G, Rodríguez del Rincón E, Velázquez López J
Departamento de Radioterapia (Sevicio de Oncología), Hospital 20 de Noviembre del Instituto de Seguridad Social al Servicio de los Trabajadores del Estado, México, D.F.
Ginecol Obstet Mex. 1995 Jun;63:256-61.
Between 1966 and 1983 we selected 209 patients with colorectal adenocarcinomas, stage B (14%) and C (86%) of Dukes, treated with convenient surgery in 100% of cases, 5-fluorouracil in 85% and postoperative radiotherapy with telecobalt in 46.41% of cases, doses of 5000 to 5500 cGy in 25 to 30 fractions. The results at five years postsurgery were: colon patients who received radiotherapy obtained a survival rate of 34 months versus 17 months for those who did not receive radiotherapy; rectum patients who received radiotherapy survival rate of 20 months versus 26 months for those who did not received. Local recurrences in patients who received radiotherapy were 9.30% for carcinomas of the colon and 11.53% for those with cancer of the rectum, and in patients who did not received radiotherapy local recurrences were 22.22% for those with cancer of the colon and 37.83% for those with cancer of the rectum.
1966年至1983年间,我们选取了209例结肠直肠癌患者,其中杜克B期(14%)和C期(86%),所有病例均采用简便手术治疗,85%的病例使用5-氟尿嘧啶,46.41%的病例采用钴远距离术后放疗,剂量为5000至5500厘戈瑞,分25至30次照射。术后五年的结果如下:接受放疗的结肠癌患者生存率为34个月,未接受放疗的患者为17个月;接受放疗的直肠癌患者生存率为20个月,未接受放疗的患者为26个月。接受放疗的患者中,结肠癌局部复发率为9.30%,直肠癌为11.53%;未接受放疗的患者中,结肠癌局部复发率为22.22%,直肠癌为37.83%。